In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
If you have been NEWLY DIAGNOSED START HERE
Welcome Home Sidebar Block
VIDEOS
In April of 2020, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy had a candid discussion regarding telemedicine in the time of...
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center discusses COVID 19 and how it...
In partnership with Clinical Care Options, GRACE Founder and President H. Jack West, MD provides this informational video regarding immunotherapy for...
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center interviews Julia Maues, breast...
ARTICLES
The medical community has made significant progress in understanding that lung cancer is not a single cancer, and are treating it accordingly. We’ve...
Probably the most immediate potentially practice-changing presentation from ASCO was the Japanese J-ALEX study in the subset of about 4-5% of patients...
It seemed inevitable, I think. Several immuntherapy agents known as PD-1 or PD-L1 checkpoint inhibitors have been shown to lead to better survival...
After completing my unpacking from ASCO and beginning to see a path of light as I dig out from under the backup of work that accumulated, I wanted to...
For patients with an activating EGFR mutation and who develop “acquired resistance”, the pattern of progression that occurs after a sometimes long...
COMMUNITY FORUM
I am new here looking for advice if this is a right place. Annual CT scans have identified a stable right upper lobe Ground Glass Nodule (GGN)...
My wife is taking treatment for EGFR mutant lung cancer that had spread to her brain. She started with tagrisso and later after resistant went thru...
Hi, my sister (47 YO, Seattle, WA) was diagnosed with lung cancer (non small cell adenocarcinoma) spring 2019. She had symptoms for a year before that...
The ADAURA clinic trial has proven that patients taking Tagrisso with IB-IIIA NSCLC had a 79% reduction in disease recurrence and the disease free...
My sister was diagnosed with IMA lung cancer this July. It was found during the physical exam. She is 55 years old, otherwise very healthy and active...